课题基金 / 基金详情

POG 9571 IRINOTECAN IN CHILDREN WITH SOLID TUMORS

POG 9571 IRINOTECAN IN CHILDREN WITH SOLID TUMORS
POG 9571 伊立替康治疗患有实体瘤的儿童
批准号：
6279207
负责人：
FAITH H KUNG
金额：
$1.43万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-12-01 至 1998-11-30
来源：
https://reporter.nih.gov/project-details/6279207
关键词：
antineoplastics child (0-11) clinical research clinical trial phase I cytotoxicity dosage drug adverse effect drug screening /evaluation human subject human therapy evaluation neoplasm /cancer chemotherapy pharmacokinetics

项目摘要

项目成果

FAITH H KUNG的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Determine qualitative and quantitative toxicity of irinotecan administered as IV infusion, establish maximum tolerated dose that results in tolerable toxicity, characterize the pharmacokinetics and observe anti-tumor effects during escalating dose of drug.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
POG 9575 TOPOTECAN FOR REFRACTORY LEUKEMIA
POG 9426 TREATMENT OF HODGKINS DISEASE WITH DBVE AND IRRADIATION
POG 9572 BYROSTATIN IN CHILDREN WITH SOLID TUMORS
POG9470--CI 980 IN CHILDREN WITH SOLID TUMORS